Status:
COMPLETED
Effects of an Acute Dose of Caffeine on the Performance of CrossFit Athletes
Lead Sponsor:
Democritus University of Thrace
Conditions:
Healthy, Young Adults
Athletic Performance
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
The goal of this clinical trial was to investigate the effect of an acute dose of caffeine on CrossFit performance in young, healthy male CrossFit athletes. The main questions it aimed to answer were ...
Detailed Description
Preliminary measurements The preliminary measurements included anthropometry, body composition estimation, dietary and habitual caffeine consumption assessment. To assess habitual caffeine consumption...
Eligibility Criteria
Inclusion
- Men
- Aged 18-40
- At least 2 years of experience with CrossFit programs
- Free of any medical condition that prevents the participant from performing the exercises of the training program at maximum capacity
Exclusion
- Consumption of caffeine and guarana supplements, unless were discontinued for at least two weeks before participating in the study
Key Trial Info
Start Date :
January 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 29 2022
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT06891469
Start Date
January 22 2022
End Date
May 29 2022
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stefanos Karalis Indoors Facilities
Athens, Byron, Greece, 16231